Publikationen in Zusammenarbeit mit Forschern von Dresden University of Technology (14)

2023

  1. Effect of Regular Consumption of a Miraculin-Based Food Supplement on Taste Perception and Nutritional Status in Malnourished Cancer Patients: A Triple-Blind, Randomized, Placebo-Controlled Clinical Trial-CLINMIR Pilot Protocol

    Nutrients, Vol. 15, Núm. 21

2020

  1. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

    Cancer Research, Vol. 80, Núm. 3, pp. 624-638

  2. The clinical, histologic, and genotypic spectrum of SEPN1-related myopathy: A case series

    Neurology, Vol. 95, Núm. 11, pp. e1512-e1527

2019

  1. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

    Nature Communications, Vol. 10, Núm. 1

  2. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248

  3. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656

  4. Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts

    Radiotherapy and Oncology, Vol. 133, pp. 163-166

2017

  1. Reply to the Editor—On misuse of null hypothesis testing: Analysis of biophysical model simulations

    Heart Rhythm

2016

  1. Balance between sodium and calcium currents underlying chronic atrial fibrillation termination: An in silico intersubject variability study

    Heart Rhythm, Vol. 13, Núm. 12, pp. 2358-2365

  2. Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

    Breast Cancer Research, Vol. 18, Núm. 1

2015

  1. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 6, pp. 1124-1131

2014

  1. Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study

    Bone, Vol. 58, pp. 48-54

2012

  1. Improving patient-physician dialog: Commentary on the results of the MS Choices survey

    Patient Preference and Adherence

2009

  1. Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: A randomized, blinded, phase 3 trial

    Journal of Bone and Mineral Research, Vol. 24, Núm. 1, pp. 153-161